Showing results (1-10 of 185) with videos related to
Sort By:
Pageof 19
International Journal of Clinical Oncology|December 25, 2015
Effects of sorafenib combined with low-dose interferon therapy for advanced hepatocellular carcinoma: a pilot studyNorio Itokawa, Masanori Atsukawa, Akihito Tsubota, et al.Plos One|July 11, 2019
Single nucleotide polymorphisms associated with elevated alanine aminotransferase in patients receiving asunaprevir plus daclatasvir combination therapy for chronic hepatitis CKeizo Kato, Noritomo Shimada, Masanori Atsukawa, et al.Journal of Nippon Medical School = Nippon Ika Daigaku Zasshi|May 8, 2018
A Case of Sjögren's Syndrome Complicated with Interstitial Nephritis and Delayed Onset Autoimmune HepatitisTakehisa Yamada, Megumi Fukui, Tetsuya Kashiwagi, et al.Journal of Nippon Medical School = Nippon Ika Daigaku Zasshi|March 11, 2021
Development of Interferon-Free, Direct-Acting Antivirals Treatment for Japanese Patients with Chronic Hepatitis C Infection and Chronic Kidney DiseaseMasanori Atsukawa, Chisa Kondo, Tadamichi Kawano, et al.World Journal of Gastroenterology|June 9, 2016
Usefulness of portal vein pressure for predicting the effects of tolvaptan in cirrhotic patientsAi Nakagawa, Masanori Atsukawa, Akihito Tsubota, et al.Hepatology Research : the Official Journal of the Japan Society of Hepatology|January 9, 2020
Relationship between serum vitamin D level and sarcopenia in chronic liver diseaseTomomi Okubo, Masanori Atsukawa, Akihito Tsubota, et al.Journal of Gastroenterology and Hepatology|September 17, 2013
Effects of fasudil on the portal and systemic hemodynamics of patients with cirrhosisTakeshi Fukuda, Yoshiyuki Narahara, Hidenori Kanazawa, et al.Journal of Nippon Medical School = Nippon Ika Daigaku Zasshi|August 4, 2020
Hemochromatosis and Hepatocellular Carcinoma Secondary to Immunoglobulin G4-Related Disease with Hepatopathy: A Case ReportShintaro Kanaka, Youichi Kawano, Shigeki Yokomuro, et al.Journal of Medical Virology|May 13, 2015
Vitamin D-related gene polymorphisms do not influence the outcome and serum vitamin D level in pegylated interferon/ribavirin therapy combined with protease inhibitor for patients with genotype 1b chronic hepatitis CTaeang Arai, Masanori Atsukawa, Akihito Tsubota, et al.Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|June 2, 2014
Serum 25(OH)D3 levels affect treatment outcomes for telaprevir/peg-interferon/ribavirin combination therapy in genotype 1b chronic hepatitis CMasanori Atsukawa, Akihito Tsubota, Noritomo Shimada, et al.Pageof 19